# Cannabis and Anxiety Risk: Long-Term Study Insights > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-and-anxiety-risk-long-term-study-march-2026/ > **Published:** 2026-03-02T23:29:11-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:13:04-04:00 > **Clinical Summary:** Explore the latest longitudinal study on cannabis and anxiety risk, highlighting dose-dependent effects and clinical implications for long-term use. --- Last 9 Hours March 02, 2026 — 1 articles reviewed This cycle’s coverage centered on a single but important theme: the longitudinal relationship between regular [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and anxiety outcomes. A decade-long Canadian cohort study drew attention for its dose-dependent findings linking frequent [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) to increased anxiety risk in vulnerable populations. Short-term relief is not the same as long-term safety, and this study is a strong reminder that patient selection and dosing discipline are not optional in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). When patients tell us cannabis “helps their anxiety,” our job is to hold space for that experience while also ensuring they understand what the longitudinal evidence actually shows. Browse all recent articles at [cedclinic.com/category/cannabis-news/](https://cedclinic.com/category/cannabis-news/) Digest-Level Clinical Commentary Dr. Caplan’s Take Clinical Reflection The emerging longitudinal evidence from Canadian cohort data reinforces what I’m observing clinically: that dose and frequency of cannabis use demonstrate a concerning dose-dependent relationship with anxiety progression in regular users, which challenges the common patient narrative that cannabis reliably manages anxiety symptoms. This finding suggests I need to be more rigorous in distinguishing between acute anxiolytic effects some patients report and the paradoxical long-term anxiety outcomes documented in prospective studies, particularly when counseling patients about chronic use patterns. Going forward, I’m emphasizing lower-frequency dosing strategies and CBT integration for my patients with anxiety rather than defaulting to cannabis as monotherapy. Clinical Perspective Clinical Perspective Recent longitudinal evidence continues to document a dose-dependent association between regular cannabis use and increased anxiety symptoms, reinforcing existing clinical observations about potential psychiatric risks with frequent consumption. These findings underscore the importance of screening cannabis use patterns during anxiety assessments and counseling patients—particularly those with baseline anxiety vulnerability—about cumulative exposure risks. As [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) expands access, clinicians should remain attentive to distinguishing between acute anxiety effects and longer-term neurobiological changes that may alter treatment approaches for affected patients. [Cannabis And Anxiety](https://cedclinic.com/dose-dependence-delta-9-thc-place-conditioning/)ResearchPublic HealthCanadaLongitudinal Studies 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Daily+Digest%3A+Last+9+Hours%3A+Cannabis+and+Anxiety+Risk+in+the+Long+Run+%E2%80%94+March+02%2C+2026+%40drcaplan&url=) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Daily+Digest%3A+Last+9+Hours%3A+Cannabis+and+Anxiety+Risk+in+the+Long+Run+%E2%80%94+March+02%2C+2026+--+via+%40drcaplan.bsky.social+) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Daily Digest: Last 38 Hours: Cannabinoids, Liver Disease, and the Adolescent Brain — March 08, 2026](https://cedclinic.com/cannabinoid-drug-delivery-breakthroughs-march-2026/) - [In the Mix: 20 More Articles — March 08, 2026](https://cedclinic.com/cannabis-pediatric-exposure-toxicity-march-08-2026/) - [Daily Digest: Last 24 Hours: Cannabinoids and Liver Disease Lead a Research-Heavy Cycle — March 08, 2026](https://cedclinic.com/cbd-cbg-fatty-liver-disease-research-march-2026/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Major study finds strong link between cannabis, anxiety and depression – Medical Xpress](https://cedclinic.com/bidirectional-cannabis-anxiety-depression-link/) This article explores a major study revealing significant associations between cannabis use and increased anxiety and depression risks. [Read More](https://cedclinic.com/bidirectional-cannabis-anxiety-depression-link/) [Teens Who Use Cannabis Face Higher Risk Of Mental Disorders, Study Finds – Forbes](https://cedclinic.com/teen-cannabis-use-mental-health-risks-study/) A study highlighting the elevated risk of [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/) among adolescent cannabis users, emphasizing early intervention. [Explore Study](https://cedclinic.com/teen-cannabis-use-mental-health-risks-study/) [Cannabis Use and Brain Aging: What a Major Study Reveals – Born2Invest](https://cedclinic.com/cannabis-use-brain-aging-insights-major-study/) Insights into how cannabis use may impact brain aging, with implications for anxiety and cognitive health over time. [Learn More](https://cedclinic.com/cannabis-use-brain-aging-insights-major-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).